Amgen to buy Horizon Therapeutics in $26.4 billion deal
[ad_1]
Amgen will acquire Horizon Therapeutics, which focuses on treatments for rare, autoimmune diseases, in a deal valued at approximately $26.4 billion.
[ad_2]
Source link
- Türkiye’s defense exports this year to top $4B, says president
- Iran blacklists more EU, UK officials in tit-for-tat move
